T1	Participants 130 189	<65 years with poor prognosis histologically aggressive NHL
T2	Participants 212 224	457 patients
T3	Participants 316 432	patients with poor prognosis histologically aggressive non-Hodgkin lymphoma (NHL) showing a response to initial CHOP
